ACM Global Laboratories Names New Director of Clinical Trials Operations at York Facility
Former Covance and GSK Scientist Lee Goodwin brings Extensive Professional Experience and Regional Knowledge to ACM’s York Lab Facility
Rochester, NY, Dec. 11, 2017 – ACM Global Central Laboratories, the largest independent central lab in the industry specializing in high-quality central laboratory testing and diagnostic lab services, today announced that Lee Goodwin has been appointed the new Director of Clinical Trials Operations for the United Kingdom. In this role, Lee is responsible for managing and leading clinical trials and its staff at the ACM facility in York. His responsibilities include ensuring clinical trials operations meet internal and external quality assurance and control standards along with overseeing the operational quality and delivery to clients in conjunction with Chief Operating Officer John Byerley.
Lee joins ACM from Covance, where he most recently served as director of the Early Development Chemistry Global Project Management group. Earlier in his career, he was part of the Worldwide Bioanalysis group at GlaxoSmithKline (GSK), Ware, working as a technical specialist and team leader in Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). He then joined Covance as method development manager within the LC-MS/MS Bioanalysis group before progressing to associate director of the department. He also served as director, bioanalysis (Europe) for Covance with responsibility for toxicokinetic, pharmacokinetic and immunogenicity testing from early discovery through to late stage clinical. Lee obtained a bachelor’s degree in biochemistry and a doctorate in chemistry from the University of York. He is a Chartered Chemist (CChem) and a Fellow of the Royal Society of Chemistry (FRSC).
Earlier this year, ACM announced the expansion of its European laboratory operations with a new, state-of-the-art facility in York, England in response to growing client demand for its clinical trials testing services throughout the region. The new European hub is nearly twice the size of its previous facility in York and serves as home to ACM’s expanding laboratory operations, as well as to its growing staff of data analysts, project managers and quality assurance specialists. 

To learn more information on ACM's central lab services, please call 1-866-405-0400 or visit www.acmgloballab.com.
About ACM Global Laboratories
ACM Global Laboratories, an affiliate of Rochester Regional Health, is the largest independent central lab in the industry. With a singular focus on testing, ACM delivers high-quality central laboratory testing and diagnostic lab services in support of both clinical trials research and individual patient care. Through a powerful combination of robust global capabilities, operational and scientific expertise and unsurpassed service, ACM provides the optimal mix of testing and related services to meet the needs and requirements of its clients in the most effective and cost-efficient manner possible. Operating in more than 60 countries, ACM performs more than 20 million tests each year spanning all medical disciplines, including pathology, microbiology, molecular diagnostics, toxicology, and more. For more information, visit www.acmgloballab.com  or call +1 866 405 0400.

email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement